Monitoring the Session

HB 214

bill letting cancer research money fund endometriosis studies

Filed

Verdict: No flags

No flagsInitial review
Rep. Mihaela PlesaDHouse 70

Initial review · graded Nov 9, 2026 · How we grade

Caption

relating to the authority of the Cancer Prevention and Research Institute of Texas to award grants for endometriosis research.

Caption from analyzed text · version I.

Summary

Cancer fund grants can go to endometriosis research, starting 2027.

The bill lets the state cancer research institute award grants for endometriosis research, including whether endometriosis leads to cancer and the causes, markers and treatment of endometriosis itself. It touches the Cancer Prevention and Research Institute of Texas, its research fund, and universities and research centers that apply for grants. On the ground, money in the cancer research fund can now go to endometriosis studies starting September 1, 2027.

Receipt

The receipt

90R-HB214 · 2026-11-09

SOLD BY

ITEM

relating to the authority of the Cancer Prevention and Research Institute of Texas to award grants for endometriosis research.

WHAT IT DOES

Cancer fund grants can go to endometriosis research, starting 2027.

The bill lets the state cancer research institute award grants for endometriosis research, including whether endometriosis leads to cancer and the causes, markers and treatment of endometriosis itself. It touches the Cancer Prevention and Research Institute of Texas, its research fund, and universities and research centers that apply for grants. On the ground, money in the cancer research fund can now go to endometriosis studies starting September 1, 2027.

CHARGES

[ ] NONE FOUND

TOTAL

No fiscal note in the loaded record.

HISTORY

  1. Filed
FILED UNDER

No verified beat found.

No flags

THANK YOU FOR CHECKING THE RECEIPT

CAMPAIGN PAID FOR BY

CAMPAIGN PAID FOR BY

Donors

Not tied to this bill.

Sources

The author's campaign account only. Own money and internal transfers are separate on the member page.

Derived itemized flow · Oct 27, 2024 to Oct 24, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Texas REALTORS Political Action Committee$79,480.35

Texas REALTORS Political Action Committee

$79,480.35

Cash
$37,500.00
Paid by others
$41,980.35
Total
$79,480.35
mail $33,992.76digital $4,945.63text $2,016.96advertising $525.00fundraiser $500.00

Also funds 140 other sitting lawmakers.

Derived recipient stock · Jul 2, 2024 to Oct 24, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Oct 31, 2024 to Oct 20, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101012300, 101032600, 101059513, 101069108, 101072533.

Texas Trial Lawyers Association PAC$55,000.00

Texas Trial Lawyers Association PAC

$55,000.00

Cash
$55,000.00
Paid by others
$0.00
Total
$55,000.00

Also funds 137 other sitting lawmakers.

Derived recipient stock · Jul 24, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Dec 11, 2024 to Sep 21, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101012300, 101032600, 101059513, 101069108.

TexBlue Media PAC$32,511.00

TexBlue Media PAC

$32,511.00

Cash
$0.00
Paid by others
$32,511.00
Total
$32,511.00
advertising $32,511.00

Also funds 0 other sitting lawmakers.

Derived recipient stock · Sep 25, 2026 to Sep 27, 2026. State data as of Nov 4, 2026.

TEC account match.

Sources

Derived itemized flow · Sep 25, 2026 to Sep 27, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101072533.

Money

Missing data does not establish zero giving. Display amounts are rounded.

×

Texas REALTORS Political Action Committee

$79,480.35

Cash
$37,500.00
Paid by others
$41,980.35
Total
$79,480.35
mail $33,992.76digital $4,945.63text $2,016.96advertising $525.00fundraiser $500.00

Also funds 140 other sitting lawmakers.

Derived recipient stock · Jul 2, 2024 to Oct 24, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Oct 31, 2024 to Oct 20, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101012300, 101032600, 101059513, 101069108, 101072533.

×

Texas Trial Lawyers Association PAC

$55,000.00

Cash
$55,000.00
Paid by others
$0.00
Total
$55,000.00

Also funds 137 other sitting lawmakers.

Derived recipient stock · Jul 24, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Dec 11, 2024 to Sep 21, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101012300, 101032600, 101059513, 101069108.

×

TexBlue Media PAC

$32,511.00

Cash
$0.00
Paid by others
$32,511.00
Total
$32,511.00
advertising $32,511.00

Also funds 0 other sitting lawmakers.

Derived recipient stock · Sep 25, 2026 to Sep 27, 2026. State data as of Nov 4, 2026.

TEC account match.

Sources

Derived itemized flow · Sep 25, 2026 to Sep 27, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101072533.

Votes

No floor vote loaded for this bill.

Fiscal

No fiscal note in the loaded record.

How this was graded

Analysis of text version I by a super-expensive superintelligence, Nov 9, 2026, against the published rubric.

Sources

Texas House · Filed Nov 9, 2026

11/09/2026 H Filed

Texas Legislature Online · Introduced

Data snapshot Nov 10, 2026 at 2:31 AM CST. Grades, charges, quotes and corrections follow the published record.

Subjects

Health--Other Diseases & Medical Conditions

CANCER

RESEARCH & DEVELOPMENT

Text

The text as introduced · 688 words

90R1728 KRM-D

By: Plesa
H.B. No. 214

A BILL TO BE ENTITLED

AN ACT

relating to the authority of the Cancer Prevention and Research

Institute of Texas to award grants for endometriosis research.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Section 102.002, Health and Safety Code, is

amended to read as follows:

Sec. 102.002. PURPOSES. The Cancer Prevention and Research

Institute of Texas is established to:

(1) create and expedite innovation in the area of

cancer research and in enhancing the potential for a medical or

scientific breakthrough in the prevention of cancer and cures for

cancer , including research on whether endometriosis may lead to or

increase the incidence of cancer in humans ;

(2) attract, create, or expand research capabilities

of public or private institutions of higher education and other

public or private entities that will promote a substantial increase

in cancer research and in the creation of high-quality new jobs in

this state; and

(3) develop and implement the Texas Cancer Plan.

SECTION 2. Section 102.051(a), Health and Safety Code, is

amended to read as follows:

(a) The institute:

(1) may award [ make ] grants to provide funds to public

or private persons to implement the Texas Cancer Plan, and may award

[ make ] grants to institutions of learning and to advanced medical

research facilities and collaborations in this state for:

(A) research into the causes of and cures for all

types of cancer in humans , including research on whether

endometriosis leads to or increases the incidence of cancer and the

causes of, biological markers of, and treatment efficacy for

endometriosis ;

(B) facilities for use in research into the

causes of and cures for cancer;

(C) research, including translational research,

to develop therapies, protocols, medical pharmaceuticals, or

procedures for the cure or substantial mitigation of all types of

cancer in humans; and

(D) cancer prevention and control programs in

this state to mitigate the incidence of all types of cancer in

humans;

(2) may support institutions of learning and advanced

medical research facilities and collaborations in this state in all

stages in the process of finding the causes of all types of cancer

in humans and developing cures, from laboratory research to

clinical trials and including programs to address the problem of

access to advanced cancer treatment;

(3) may establish the appropriate standards and

oversight bodies to ensure the proper use of funds authorized under

this chapter for cancer research and facilities development;

(4) may employ necessary staff to provide

administrative support;

(5) shall continuously monitor contracts and

agreements authorized by this chapter and ensure that each grant

recipient complies with the terms and conditions of the grant

contract;

(6) shall ensure that all grant proposals comply with

this chapter and rules adopted under this chapter before the

proposals are submitted to the oversight committee for approval;

and

(7) shall establish procedures to document that the

institute, its employees, and its committee members appointed under

this chapter comply with all laws and rules governing the peer

review process and conflicts of interest.

SECTION 3. Section 102.201(c), Health and Safety Code, is

amended to read as follows:

(c) The fund may be used only to pay for:

(1) grants for cancer research and for cancer research

facilities in this state to realize therapies, protocols, and

medical procedures for the cure or substantial mitigation of all

types of cancer in humans , including research on whether

endometriosis leads to or increases the incidence of cancer and the

causes of, biological markers of, and treatment efficacy for

endometriosis ;

(2) the purchase, subject to approval by the

institute, of laboratory facilities by or on behalf of a state

agency or grant recipient;

(3) grants to public or private persons to implement

the Texas Cancer Plan;

(4) the operation of the institute;

(5) grants for cancer prevention and control programs

in this state to mitigate the incidence of all types of cancer in

humans; and

(6) debt service on bonds issued as authorized by

Section 67, Article III, Texas Constitution.

SECTION 4. This Act takes effect September 1, 2027.